Elevance Health Inc. Financial Ratios — ELV Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	23.82	22	18.81	18.46	17.78	15.76	22.2	19.71	22.59	19.71	24.2	20.78	19.5	18.31	16.42
Return on Assets (%)	5.17	4.78	4.2	4.24	4.15	3.9	5.67	5.28	6.45	5.57	6.69	5.89	5.66	5.3	4.75
Return on Capital (%)	14.31	12.28	10.38	10.19	9.78	9.1	12.98	11.16	13.21	11.9	14.42	12.61	12.24	11.3	10.33
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	100	100	100	100	100	100	100	100	100	100	100	100
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	6.52	6.27	5.41	5.91	5.85	5.37	4.4	5.5	5.74	5.12	5.77	4.85	4.5	4.47	3.37
Profit Margin (%)	4.36	4.32	3.51	3.48	3.23	2.91	4.27	4.07	4.61	3.75	4.44	3.76	3.49	3.38	2.84
Net Income to Common Margin (%)	4.36	4.32	3.51	3.48	3.23	2.91	4.27	4.07	4.61	3.75	4.44	3.76	3.49	3.38	2.84
Effective Tax Rate (%)	33.13	31.29	31.4	41.39	44.72	45.77	3.05	26.01	19.68	26.71	23.09	22.53	22.35	24.46	15.63
Dvd Payout Ratio (%)	13.52	13.85	17.01	18.78	25.65	27.69	18.35	20.69	17.02	20.87	17.98	20.89	23.27	25.29	27.01
Sustainable Growth Rate (%)	20.6	18.95	15.61	15	13.22	11.4	18.13	15.63	18.74	15.6	19.85	16.43	14.96	13.68	11.99

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	9,840	14,978	14,492	15,044	15,864	15,727	19,932	19,211	20,085	20,035	23,031	24,114	25,120	31,232	32,046
ST Debt	1,374	807	918	1,024	540	1,368	2,550	1,994	2,298	700	1,874	1,765	1,874	2,014	1,249
LT Debt	8,466	14,171	13,574	14,020	15,324	14,358	17,382	17,217	17,787	19,335	21,157	22,349	23,246	29,218	30,797
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	-1.21	-1.06	-1.07	-1.19	-0.98	-0.81	-1.07	-1.6	-1.44	-1.3	-1.36	-1.35	-1.26	-1.06	-0.8
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	430	512	603	601	653	723	739	753	746	784	798	851	1,030	1,185	1,402
Common Equity/Total Assets	22.03	21.46	23.19	22.73	23.95	25.45	25.6	27.93	29.15	27.48	27.8	28.85	29.15	28.7	29.13
Long-Term Debt/Equity (%)	36.35	59.53	54.81	57.81	66.5	57.2	65.59	60.32	56.06	58.24	58.56	61.52	58.99	70.53	69.95
Long-Term Debt/Capital (%)	39.68	51.29	47.95	48.24	50.01	44.47	45.76	43.92	41.69	44.1	42.15	41.5	40.8	45.02	45.57
Long-Term Debt/Total Assets (%)	16.23	24.04	22.78	22.73	24.83	22.06	24.64	24.06	22.96	22.32	21.71	21.75	21.34	25	25.35
Total Debt/Equity (%)	42.25	62.93	58.52	62.03	68.84	62.66	75.21	67.31	63.3	60.35	63.75	66.37	63.75	75.39	72.79
Total Debt/Capital (%)	46.12	54.21	51.19	51.77	51.77	48.71	52.47	49.01	47.08	45.7	45.89	44.78	44.09	48.13	47.42
Total Debt/Total Assets (%)	18.86	25.41	24.33	24.39	25.7	24.16	28.26	26.84	25.93	23.13	23.63	23.47	23.06	26.72	26.38
Net Debt to Equity	32.8	52.53	52.13	53.16	59.67	46.42	61.59	53.53	47.74	43.06	50.24	46.04	47.19	55.39	51.23
Net Debt/Capital (%)	39.92	49.71	48.3	47.91	48.19	41.3	47.48	43.32	40.15	37.52	40.06	36	36.86	40.53	38.83
EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx	-520	-545	-646	-715	-638	-584	-791	-1,208	-1,077	-1,021	-1,087	-1,152	-1,296	-1,256	-1,116
Operating Income (Loss)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Current Ratio	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Quick Ratio	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
CFO/Avg Current Liab	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	22.03	21.46	23.19	22.73	23.95	25.45	25.6	27.93	29.15	27.48	27.8	28.85	29.15	28.7	29.13
Long-Term Debt/Equity (%)	36.35	59.53	54.81	57.81	66.5	57.2	65.59	60.32	56.06	58.24	58.56	61.52	58.99	70.53	69.95
Long-Term Debt/Capital (%)	39.68	51.29	47.95	48.24	50.01	44.47	45.76	43.92	41.69	44.1	42.15	41.5	40.8	45.02	45.57
Long-Term Debt/Total Assets (%)	16.23	24.04	22.78	22.73	24.83	22.06	24.64	24.06	22.96	22.32	21.71	21.75	21.34	25	25.35
Total Debt/Equity (%)	42.25	62.93	58.52	62.03	68.84	62.66	75.21	67.31	63.3	60.35	63.75	66.37	63.75	75.39	72.79
Total Debt/Capital (%)	46.12	54.21	51.19	51.77	51.77	48.71	52.47	49.01	47.08	45.7	45.89	44.78	44.09	48.13	47.42
Total Debt/Total Assets (%)	18.86	25.41	24.33	24.39	25.7	24.16	28.26	26.84	25.93	23.13	23.63	23.47	23.06	26.72	26.38
CFO/Total Liabilities	11.69	7.81	8.77	9	10.89	8.18	9.5	8.89	13.26	20.01	13.64	12.64	11.59	7.7	5.54
CFO/CapEx	6.5	5.04	4.72	4.71	6.6	5.6	5.29	3.17	5.63	10.47	7.69	7.29	6.22	4.62	3.84
Altman's Z-Score	3	2.69	3.11	3.09	3.34	3.3	3.47	3.8	3.82	3.68	3.92	4.01	3.89	3.59	3.63

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	18.84	17.35	18.55	16.8	16.79	16.22	14.95	14.25	17.73	23.68	25.3	24.54	22.87	22.22	22.02
Days Sales Outstanding	19.37	21.04	19.67	21.73	21.74	22.5	24.42	25.62	20.59	15.41	14.43	14.88	15.96	16.43	16.57
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	22,483	18,563	27,096	33,693	36,427	37,919	57,622	67,600	76,390	78,796	112,070	122,065	109,907	83,917	77,375
- Cash & Cash Equivalents	2,202	2,475	1,582	2,152	2,114	4,075	3,609	3,934	4,937	5,741	4,880	7,387	6,526	8,288	9,491
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	68	87	99	111	144
+ Total Debt	9,840	14,978	14,492	15,044	15,864	15,727	19,932	19,211	20,085	20,035	23,031	24,114	25,120	31,232	32,046
Enterprise Value	14,194	14,138	22,951	29,098	33,239	32,392	56,551	66,164	71,862	69,657	104,022	112,927	98,986	81,771	74,190
Total Capital	21,334	27,628	28,308	29,061	30,646	32,290	37,989	39,202	42,661	43,840	50,189	53,850	56,970	64,894	67,585
Total Debt/Capital (%)	46.12	54.21	51.19	51.77	51.77	48.71	52.47	49.01	47.08	45.7	45.89	44.78	44.09	48.13	47.42
Total Debt / EV	0.69	1.06	0.63	0.52	0.48	0.49	0.35	0.29	0.28	0.29	0.22	0.21	0.25	0.38	0.43
EV/Sales	0.23	0.23	0.32	0.39	0.42	0.38	0.63	0.72	0.69	0.57	0.75	0.72	0.58	0.46	0.37
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	3.88	4.57	6.62	7.82	7.27	8.85	11.54	15.09	10.79	6.18	11.59	12.47	11.17	12.2	13.56
EV/Free Cash Flow to Firm	3.39	3.88	5.58	6.56	6.38	7.63	9.93	11.83	9.29	5.67	10.34	11.06	9.75	10.27	11.26
Diluted Market Cap	24,188	19,787	28,068	35,929	38,053	38,545	60,258	69,387	78,618	81,653	114,402	124,549	111,948	85,917	78,734
Diluted Enterprise Value	31,826	32,289	40,978	48,821	51,804	50,196	76,581	84,664	93,766	95,947	132,621	141,363	130,641	108,972	101,433
EV per Share	41.82	46.4	78.26	108.53	127.24	122.81	220.83	257.05	284.13	283.85	430.25	474.57	424.7	359.47	336.12
TTM Sales	60,711	61,497	71,024	73,874	79,156	84,863	90,040	92,105	104,213	121,867	138,639	156,595	171,340	176,810	199,125
TTM EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM Operating Income	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM Cash Flow to Firm	3,662	3,096	3,466	3,721	4,573	3,662	4,901	4,384	6,660	11,263	8,978	9,058	8,861	6,703	5,473
TTM Free Cash Flow to Firm	4,182	3,641	4,112	4,436	5,211	4,246	5,692	5,592	7,737	12,284	10,065	10,210	10,157	7,959	6,589

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	6.21	6.02	7.59	8.8	7.85	10	12.11	13.78	11.01	6.97	12.1	13.04	11.96	12.16	14.56
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	14,194	14,138	22,951	29,098	33,239	32,392	56,551	66,164	71,862	69,657	104,022	112,927	98,986	81,771	74,190
Low Price	56.61	52.52	58.75	81.84	122.86	114.85	140.5	215.52	227.16	171.03	286.04	420.73	412	362.21	273.71
EV/Sales	0.23	0.23	0.32	0.39	0.42	0.38	0.63	0.72	0.69	0.57	0.75	0.72	0.58	0.46	0.37
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	8.49	6.99	10.88	13.11	14.23	15.35	14.99	18.03	15.89	17.23	18.2	20.71	18.36	14.03	13.67
Price/Earnings Average	8.8	7.27	9.24	11.29	15.06	14.24	12.37	17.18	14.62	14.97	14.79	19.56	18.03	18.81	14.12
Price/Earnings High	10.5	8.58	11.12	13.56	17.71	15.83	15.75	20.63	16.73	18.15	18.45	22.19	19.93	21.58	17.88
Price/Earnings Low	7.26	6.03	6.92	8.54	12.54	12.26	9.36	14.79	11.95	9.18	11.23	16.99	16.04	13.78	10.67
Price/Book Value	1.96	1.47	1.96	2.4	2.46	2.29	3.19	3.38	3.38	3.31	4.14	4.12	3.46	2.5	2.19
Price/Book Value Average	2.03	1.53	1.67	2.07	2.61	2.12	2.63	3.22	3.11	2.88	3.36	3.89	3.4	3.35	2.26
Price/Book Value High	2.42	1.8	2	2.49	3.07	2.36	3.35	3.87	3.56	3.49	4.19	4.41	3.76	3.85	2.86
Price/Book Value Low	1.67	1.27	1.25	1.57	2.17	1.83	1.99	2.77	2.54	1.76	2.55	3.38	3.02	2.46	1.71
Price/Tangible Book Value	15.01	-10.59	-45.69	-42.71	-13.61	-89.07	-52.57	-69.69	29.91	37.47	87.21	74.79	28.81	79.54	17.26
Price/Tangible Book Value Average	15.55	-11.02	-38.8	-36.76	-14.4	-82.63	-43.37	-66.42	27.51	32.55	70.88	70.65	28.3	106.62	17.84
Price/Tangible Book Value High	18.56	-12.99	-46.67	-44.17	-16.95	-91.86	-55.23	-79.76	31.49	39.46	88.43	80.12	31.28	122.31	22.59
Price/Tangible Book Value Low	12.83	-9.13	-29.06	-27.82	-11.99	-71.16	-32.83	-57.19	22.5	19.96	53.82	61.35	25.17	78.1	13.48
Price/Sales	0.37	0.3	0.38	0.46	0.46	0.45	0.64	0.73	0.73	0.65	0.81	0.78	0.64	0.47	0.39
Price/Sales Average	0.38	0.31	0.32	0.39	0.49	0.41	0.53	0.7	0.67	0.56	0.66	0.74	0.63	0.64	0.4
Price/Sales High	0.46	0.37	0.39	0.47	0.57	0.46	0.67	0.84	0.77	0.68	0.82	0.84	0.7	0.73	0.51
Price/Sales Low	0.32	0.26	0.24	0.3	0.41	0.36	0.4	0.6	0.55	0.34	0.5	0.64	0.56	0.47	0.3
Price/Cash Flow	6.66	6.76	8.88	10	8.65	11.6	13.77	17.66	12.6	7.37	13.4	14.53	13.63	14.45	18.04
Price/Cash Flow Average	6.9	7.04	7.54	8.61	9.15	10.76	11.36	16.84	11.59	6.4	10.89	13.73	13.39	19.37	18.64
Price/Cash Flow High	8.24	8.3	9.07	10.34	10.77	11.96	14.46	20.22	13.27	7.77	13.59	15.57	14.8	22.22	23.6
Price/Cash Flow Low	5.69	5.83	5.64	6.51	7.62	9.26	8.6	14.5	9.48	3.93	8.27	11.92	11.91	14.19	14.08
Price/Free Cash Flow Average	6.43	6.26	6.44	7.57	8.3	9.28	9.99	13.13	10.13	6.06	9.84	12.32	11.75	16.3	15.05
Price/Free Cash Flow High	7.68	7.38	7.75	9.1	9.77	10.31	12.72	15.77	11.6	7.35	12.27	13.97	12.99	18.7	19.06
Price/Free Cash Flow Low	5.31	5.19	4.83	5.73	6.91	7.99	7.56	11.31	8.28	3.71	7.47	10.7	10.45	11.94	11.37
EV/Sales Average	0.51	0.52	0.51	0.57	0.66	0.55	0.71	0.87	0.82	0.68	0.79	0.84	0.74	0.77	0.52
EV/Sales High	0.58	0.57	0.57	0.65	0.75	0.6	0.85	1.01	0.92	0.8	0.95	0.94	0.81	0.86	0.62
EV/Sales Low	0.44	0.46	0.42	0.47	0.58	0.49	0.58	0.77	0.7	0.46	0.63	0.75	0.67	0.6	0.42
EV/EBITDA Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Last Price	66.25	60.92	92.39	125.67	139.44	143.77	225.01	262.63	302.03	321.09	463.54	512.97	471.56	368.9	350.55
High Price	81.92	74.73	94.36	129.96	173.59	148.26	236.39	300.57	317.99	338.2	470.02	549.52	511.97	567.26	458.75
Enterprise Value Average	30,927	31,819	35,920	41,892	52,300	46,826	63,858	79,706	85,403	82,739	109,305	132,118	126,665	135,540	102,651
Enterprise Value High	35,440	35,274	40,583	47,736	59,099	50,755	76,859	92,642	95,575	97,289	131,856	147,577	138,018	152,095	123,956
Enterprise Value Low	26,850	28,506	30,139	34,834	45,847	41,943	52,303	70,751	72,602	56,265	87,375	116,930	114,718	105,450	83,113

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	339	305	293	268	261	264	256	257	253	245	242	238	233	227	221
Diluted Weighted Avg Shares	365	325	304	286	273	268	268	264	260	254	247	243	237	233	225
Basic Weighted Avg Shares	339	305	293	268	261	264	256	257	253	245	242	238	233	227	221
Revenue per Share	178.89	201.82	242.17	275.54	303.01	321.76	351.6	357.83	412.04	496.6	573.43	658.08	735.14	777.26	902.15
EBITDA per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Income per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic EPS, GAAP	7.8	8.71	8.49	9.58	9.8	9.37	15.01	14.57	19.01	18.63	25.47	24.77	25.69	26.29	25.65
Basic EPS from Cont Ops	7.8	8.7	8.98	9.55	9.8	9.37	15.01	14.57	19.01	18.63	25.43	24.74	25.7	26.25	25.65
Diluted EPS, GAAP	7.25	8.18	8.2	8.99	9.38	9.21	14.35	14.19	18.47	17.98	24.95	24.28	25.22	25.68	25.21
Diluted EPS from Cont Ops	7.25	8.16	8.67	8.95	9.38	9.21	14.35	14.19	18.47	17.98	24.91	24.25	25.24	25.64	25.2
Dividend per Share	1.05	1.2	1.53	1.79	2.51	2.59	2.75	3.01	3.23	3.89	4.57	5.16	5.99	6.63	6.93
Cash Flow per Share	9.94	9.01	10.41	12.57	16.12	12.4	16.34	14.87	23.96	43.55	34.59	35.3	34.59	25.53	19.44
Free Cash Flow per Basic Share	8.41	7.22	8.2	9.9	13.68	10.18	13.25	10.18	19.71	39.39	30.1	30.45	29.03	20.01	14.38
Cash & Equivalents per Share	53.42	63.68	63.55	73.25	72.93	80.59	82.02	80.22	97.31	118.88	128.83	140.1	155.06	147.22	160.27
Book Value per Share	33.87	41.51	47.11	52.28	56.58	62.8	70.51	77.67	89.26	97	112.05	124.6	136.23	147.49	160.36
Tangible Book Value per Share	4.41	-5.75	-2.02	-2.94	-10.24	-1.61	-4.28	-3.77	10.1	8.57	5.31	6.86	16.37	4.64	20.31

Elevance Health Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)